137 related articles for article (PubMed ID: 8041119)
21. Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II.
Bouillé P; Subra F; Goulaouic H; Carteau S; Auclair C
Cancer Res; 1995 Jul; 55(14):3211-7. PubMed ID: 7606743
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines.
Sugimoto Y; Tsukahara S; Oh-hara T; Liu LF; Tsuruo T
Cancer Res; 1990 Dec; 50(24):7962-5. PubMed ID: 2174738
[TBL] [Abstract][Full Text] [Related]
23. Defective DNA topoisomerase II in ataxia-telangiectasia cells.
Lavin MF; Singh SP
Acta Biol Hung; 1990; 41(1-3):125-35. PubMed ID: 1965559
[TBL] [Abstract][Full Text] [Related]
24. Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.
Versantvoort CH; Withoff S; Broxterman HJ; Kuiper CM; Scheper RJ; Mulder NH; de Vries EG
Int J Cancer; 1995 May; 61(3):375-80. PubMed ID: 7729950
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering ER; Kaspers GJ; Veerman AJ
Leukemia; 1995 Oct; 9(10):1653-60. PubMed ID: 7564505
[TBL] [Abstract][Full Text] [Related]
26. Folate-binding protein mRNA is decreased in methotrexate-resistant KB cells.
Hsueh CT; Dolnick BJ
Oncol Res; 1992; 4(11-12):497-505. PubMed ID: 1299378
[TBL] [Abstract][Full Text] [Related]
27. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.
Pan SS; Forrest GL; Akman SA; Hu LT
Cancer Res; 1995 Jan; 55(2):330-5. PubMed ID: 7812966
[TBL] [Abstract][Full Text] [Related]
28. DNA topoisomerase II as a potential factor in drug resistance of human malignancies.
Potmesil M; Hsiang YH; Liu LF; Wu HY; Traganos F; Bank B; Silber R
NCI Monogr; 1987; (4):105-9. PubMed ID: 3041236
[TBL] [Abstract][Full Text] [Related]
29. A general transcription initiation factor, human transcription factor IID, overexpressed in human lung and breast carcinoma and rapidly induced with serum stimulation.
Wada C; Kasai K; Kameya T; Ohtani H
Cancer Res; 1992 Jan; 52(2):307-13. PubMed ID: 1728404
[TBL] [Abstract][Full Text] [Related]
30. Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
de Jong S; Zijlstra JG; Mulder NH; de Vries EG
Cancer Chemother Pharmacol; 1991; 28(6):461-4. PubMed ID: 1657425
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell line.
Binaschi M; Giaccone G; Gazdar AF; De Isabella P; Ricotti GC; Capranico G; Zunino F
J Natl Cancer Inst; 1992 Nov; 84(22):1710-6. PubMed ID: 1331483
[TBL] [Abstract][Full Text] [Related]
32. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
Bugg BY; Danks MK; Beck WT; Suttle DP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758
[TBL] [Abstract][Full Text] [Related]
33. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
Kim R; Hirabayashi N; Nishiyama M; Saeki S; Toge T; Okada K
Anticancer Res; 1991; 11(1):429-31. PubMed ID: 1850221
[TBL] [Abstract][Full Text] [Related]
34. Dihydrofolate reductase gene expression characterized by the PCR assay in human leukemia cells.
Miyachi H; Han H; Scanlon KJ
In Vivo; 1991; 5(1):7-12. PubMed ID: 1932630
[TBL] [Abstract][Full Text] [Related]
35. Induction of topoisomerase II gene expression in human lymphocytes upon phytohemagglutinin stimulation.
Hwong CL; Wang CH; Chen YJ; Whang-Peng J; Hwang JL
Cancer Res; 1990 Sep; 50(17 Suppl):5649S-5652S. PubMed ID: 2167162
[TBL] [Abstract][Full Text] [Related]
36. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.
Boege F; Andersen A; Jensen S; Zeidler R; Kreipe H
Am J Pathol; 1995 Jun; 146(6):1302-8. PubMed ID: 7539979
[TBL] [Abstract][Full Text] [Related]
37. Analysis of transcriptional isoforms of collagen types IX, II, and I in the developing avian cornea by competitive polymerase chain reaction.
Fitch JM; Gordon MK; Gibney EP; Linsenmayer TF
Dev Dyn; 1995 Jan; 202(1):42-53. PubMed ID: 7703520
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerase II alpha expression in acute myeloid leukaemia and its relationship to clinical outcome.
McKenna SL; West RR; Whittaker JA; Padua RA; Holmes JA
Leukemia; 1994 Sep; 8(9):1498-502. PubMed ID: 8090029
[TBL] [Abstract][Full Text] [Related]
39. Characterization of human prodynorphin gene transcripts.
Geijer T; Telkov M; Terenius L
Biochem Biophys Res Commun; 1995 Oct; 215(3):881-8. PubMed ID: 7488056
[TBL] [Abstract][Full Text] [Related]
40. The activity of topoisomerases is related to the grade and stage in human renal cell carcinoma.
Shuin T; Sano K
Anticancer Res; 1994; 14(6B):2621-6. PubMed ID: 7872691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
